4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001415889-25-002291
Chief Manuf, Strategy&Bus Dev. bought 30,000 shares at an average $5.24 ($157,200)
- Chief Manuf, Strategy&Bus Dev. acquired 12,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Murphy Sean Chief Manuf, Strategy&Bus Dev. | 2025-01-27 | Grant or award | +12,500 | 63,288 | D | ||
| Murphy Sean Chief Manuf, Strategy&Bus Dev. | 2025-01-27 | Purchase | +15,000 | $5.31 | $79,650 | 182,732 | I |
| Murphy Sean Chief Manuf, Strategy&Bus Dev. | 2025-01-28 | Purchase | +15,000 | $5.17 | $77,550 | 197,732 | I |
| Derivatives | |||||||
| Murphy Sean Chief Manuf, Strategy&Bus Dev. | 2025-01-27 | Grant or award · Employee Stock Option (right to buy) | +75,000 | 75,000 | D | ||
| Open-market purchases · 30,000 sh · avg $5.24 · $157,200 | |||||||
Loading xslF345X05/form4-01292025_110106.xml…